USMLE Step 2 CK practice question: Initial nonsevere Clostridioides difficile infection: fidaxomicin as preferred therapy

USMLE Step 2 CKGastrointestinalInternal Medicine

A 67-year-old woman is evaluated for 3 days of watery diarrhea, with 7 to 8 stools daily, and crampy lower abdominal pain. Ten days ago, she completed a course of cefpodoxime for pyelonephritis. She has had no previous episodes of diarrhea. Temperature is 37.8°C (100.0°F), pulse is 92/min, and blood pressure is 128/76 mm Hg. The abdomen is soft and mildly tender in the lower quadrants, without distention or peritoneal signs. Leukocyte count is 12,400/mm³, and serum creatinine is 0.9 mg/dL (baseline 0.8 mg/dL). Stool testing is positive for Clostridioides difficile by nucleic acid amplification and positive for toxin by enzyme immunoassay.

Which of the following is the most appropriate pharmacotherapy?

  1. Oral fidaxomicin 200 mg twice daily for 10 days
  2. Oral metronidazole 500 mg three times daily for 14 days
  3. IV vancomycin 1 g every 12 hours for 10 days
  4. Fecal microbiota transplantation by colonoscopy
  5. Oral rifaximin 550 mg three times daily for 14 days
Show answer and explanation

Correct answer: A. Oral fidaxomicin 200 mg twice daily for 10 days

Three or more unformed stools in 24 hours after antibiotic exposure, with a positive toxin assay, confirm Clostridioides difficile infection (CDI). Severity is graded by the leukocyte count and creatinine: nonsevere CDI has a leukocyte count of 15,000/mm³ or less and a creatinine below 1.5 mg/dL; severe CDI exceeds either threshold; fulminant CDI adds hypotension, shock, ileus, or megacolon. This is an initial, nonsevere episode.

The 2021 IDSA/SHEA focused update recommends fidaxomicin 200 mg twice daily for 10 days as preferred therapy for an initial episode, with oral vancomycin 125 mg four times daily for 10 days as an acceptable alternative. Fidaxomicin is a narrow-spectrum macrocyclic antibiotic that spares much of the normal colonic flora, so it achieves similar cure rates but fewer recurrences than vancomycin. Oral metronidazole is reserved for nonsevere disease when neither drug is available. Fulminant disease is treated with high-dose oral (and, with ileus, rectal) vancomycin plus IV metronidazole. The inciting antibiotic should be stopped whenever possible, and antiperistaltic agents are avoided early in treatment.

Why the other options are wrong

  • B. Oral metronidazole 500 mg three times daily for 14 days — Metronidazole is less effective and is used only for nonsevere CDI when fidaxomicin and oral vancomycin are unavailable.
  • C. IV vancomycin 1 g every 12 hours for 10 days — IV vancomycin is not excreted into the colonic lumen and is ineffective for CDI; vancomycin must be given orally or rectally.
  • D. Fecal microbiota transplantation by colonoscopy — Fecal microbiota-based therapy is reserved for multiple recurrences, not a first episode.
  • E. Oral rifaximin 550 mg three times daily for 14 days — Rifaximin has been used as a follow-on agent after treatment of recurrent CDI; it is not first-line for an initial episode.

Key point

For an initial episode of C. difficile infection, fidaxomicin is preferred, with oral vancomycin as an alternative; IV vancomycin is ineffective.

Memory hook

Fidaxomicin: fewer flora casualties, fewer comebacks. Vancomycin for C. difficile goes in by mouth; IV never reaches the colon.

Share: Telegram WhatsApp X LinkedIn

Practice like this every day

15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.

Play free

More free questions in this system

Midgut malrotation with volvulus: incomplete 270° rotation around the superior mesenteric arteryUSMLE Step 1 · GastrointestinalHereditary hemochromatosis: HFE C282Y and low hepcidinUSMLE Step 1 · GastrointestinalInferior STEMI with right ventricular infarction and hypotensionUSMLE Step 2 CK · CardiovascularDiabetic ketoacidosis with hypokalemia: potassium before insulinUSMLE Step 2 CK · EndocrineEmpiric therapy for community-acquired bacterial meningitis in an adult older than 50 yearsUSMLE Step 2 CK · NervousHepatitis B immunoprophylaxis for a preterm infant of an HBsAg-positive motherUSMLE Step 2 CK · Pediatrics

All free questions →